Day: October 17, 2022

Oct 17
Minerva Neurosciencs to request meeting with FDA about schizophrenia drug

Minerva Neurosciences Inc. NERV, -65.90% said Monday that it received a refusal to file letter from the Food and Drug Administration for its application for roluperidone as a treatment for patients with schizophrenia. “The company intends to request a Type A meeting and looks forward to continued discussions with the FDA,” Minerva CEO said in […]

Oct 17
NGM’s eye drug fails in a Phase 2 clinical trial

Shares of NGM Biopharmaceuticals Inc. NGM, -72.21% tumbled 67.4% in premarket trading on Monday after the company said its experimental treatment for an advanced form of macular degeneration did not meet the primary endpoint in a Phase 2 clinical trial. NGM said it plans to share additional information from the study at the Retina Society’s […]

Oct 17
Bank of New York Mellon shares rise after adjusted earnings and revenue top estimates

Bank of New York Mellon Corp. BK, +4.79% shares rose 3.4% in premarket trades Monday after the financial firm topped third-quarter analyst estimates for revenue and adjusted profit. Bank of New York Mellon said its third-quarter net income fell 62% to $319 million, or 39 cents a share, from $881 million, or $1.09 a share, […]

Oct 17
The cryptocurrency market digest (BTC). Overview for 17.10.2022

BTC is trying to form a directional move, but not particularly effectively. On Monday, the major cryptocurrency returned to USD 19262. In fact, there is no way to break away from the strong support area of USD 18,000-19,000. This zone keeps the flagship cryptocurrency from strong bearish pressure, but at the same time prevents it […]

Oct 17
Bank of America beats earnings target as net interest income and revenue rise

Bank of America Corp. BAC, +5.41% shares rose 2.4% in premarket trades Monday after the megabank topped earnings and revenue estimates. The bank said its third-quarter net income fell to $6.58 billion, or 81 cents a share, from $7.26 billion, or 85 cents a share, in the year-ago quarter. Revenue increased 8% to $24.5 billion. […]

Oct 17
Kanye West said to have inked a deal to acquire right-wing social-media platform Parler

Kanye West has agreed to acquire the right-wing social-media platform Parler, according to a statement by parent company Parlement Technologies on Monday. “In a world where conservative opinions are considered to be controversial we have to make sure we have the right to freely express ourselves,” West, who now goes by the name Ye, said […]

Oct 17
Binance CoinMarketCap Index Series kicks off by tracking top 10 cryptocurrencies

Starting in November 2022, Binance’s Top 10 Equal-Weighted Index will be available to investors through Auto-Invest, to track the performance of the top 10 cryptocurrencies. 2465 Total views 24 Total shares Crypto exchange Binance announced that it will launch its first index product, the Top 10 Equal-Weighted Index, to kick off its Binance CoinMarketCap Index Series. The […]

Oct 17
Microsoft stock surges, provides biggest boost to the Dow’s price

Shares of Microsoft Corp. MSFT, +3.50% surged 3.7% in morning trading Monday, to provide the biggest point boost among Dow Jones Industrial Average’s DJIA, +1.85% components. The software behemoth’s stock price gain of $8.55 added about 56 points to the Dow’s price, while the Dow rallied 545 points, or 1.8%. Microsoft’s stock rally comes even […]

Oct 17
Dow climbs nearly 600 points as stocks open sharply higher after Friday’s punishing selloff

U.S. stocks opened sharply higher on Monday, with the Dow Jones Industrial Average advancing nearly 600 points, as stocks rebounded following Friday’s punishing selloff. The S&P 500 SPX, +2.68% climbed 80 points, or 2.3%, to 3,663. The Dow DJIA, +1.84% gained 568 points, or 1.9%, to 30,203. The Nasdaq Composite COMP, +3.31% advanced 276 points, […]

Oct 17
Milestone’s stock jumps 25% on positive data for tachycardia treatment

Shares of Milestone Pharmaceuticals Inc. MIST, -2.89% gained 25.4% in premarket trading on Monday after the company said its experimental treatment for paroxysmal supraventricular tachycardia met the primary endpoint in a Phase 3 study. Paroxysmal supraventricular tachycardia is a type of arrhythmia. The treatment, etripamil, is a nasal spray. Milestone said it plans to submit […]